SAN FRANCISCO — Christopher Hazuka rejoined Latham & Watkins on Monday as a partner in the corporate department in Menlo Park. He’s returning from four years in-house at the pharmaceutical company Orexigen Therapeutics Inc., where he most recently served as acting general counsel and assistant secretary.
From 2004 until 2011, Hazuka was an associate at Latham, where he worked on intellectual property and technology-based deals. He became a Latham partner in November 2011 but left for Orexigen a month later because he wanted to be more of a generalist, he said.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
